Short Interest in Ocean Biomedical, Inc. (NASDAQ:OCEAW) Declines By 54.3%

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a large decline in short interest in February. As of February 28th, there was short interest totalling 6,900 shares, a decline of 54.3% from the February 13th total of 15,100 shares. Based on an average daily trading volume, of 59,700 shares, the short-interest ratio is presently 0.1 days.

Ocean Biomedical Trading Down 6.5 %

Ocean Biomedical stock opened at $0.02 on Friday. Ocean Biomedical has a 52 week low of $0.02 and a 52 week high of $0.42. The firm’s 50-day simple moving average is $0.03 and its 200 day simple moving average is $0.04.

Ocean Biomedical Company Profile

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.